Most Prostate Cancer Patients on Active Surveillance Don’t Follow Monitoring Guidelines, Study Shows

Most Prostate Cancer Patients on Active Surveillance Don’t Follow Monitoring Guidelines, Study Shows
Most prostate cancer patients who choose to undergo active surveillance instead of treatment are not receiving the appropriate disease monitoring, bringing into question whether or not this is a safe treatment option, according to a population-based study. The study, “Population-based cohort of prostate cancer patients on active surveillance (AS): guideline adherence, conversion to treatment and decisional regret,” was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Active surveillance, as opposed to treatment, is often recommended for patients diagnosed with early-stage prostate cancer due to the slow-growing nature of this cancer. The approach consists of actively monitoring the cancer to detect disease progression before starting any treatment, and "has rigorous guidelines," Ronald C. Chen, MD, associate professor at the UNC School of Medicine, said in a press release. "People need regular PSA [prostate-specific antigen] tests, they need prostate exams, they need prostate biopsies so you can watch the cancer very closely, and you don't lose the opportunity to treat the cancer when it starts to grow." Data from large academic institutions and clinical trials have
Subscribe or to access all post and page content.

Tagged , , , , .

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Leave a Comment

Your email address will not be published. Required fields are marked *